Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
16.04.2025 14:11:41
|
Abbott Laboratories Q1 Profit Increases, Beats Estimates
(RTTNews) - Abbott Laboratories (ABT) announced earnings for its first quarter that increased from last year and beat the Street estimates.
The company's earnings totaled $1.325 billion, or $0.76 per share. This compares with $1.225 billion, or $0.70 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $1.919 billion or $1.09 per share for the period.
Analysts on average had expected the company to earn $1.07 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 4.0% to $10.358 billion from $9.964 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $1.325 Bln. vs. $1.225 Bln. last year. -EPS: $0.76 vs. $0.70 last year. -Revenue: $10.358 Bln vs. $9.964 Bln last year.
-Guidance: Next quarter EPS guidance: $1.23 - $1.27 Full year EPS guidance: $5.05 - $5.25
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!